# GLYCOMIMETICS INC: Form D filings

GLYCOMIMETICS INC, a pharmaceuticals company in Gaithersburg, MD, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on October 27, 2010, reports $39 million sold of a $50 million offering to 15 investors.

Find out what GLYCOMIMETICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20GLYCOMIMETICS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=GLYCOMIMETICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fglycomimetics-inc-1253689)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20GLYCOMIMETICS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=GLYCOMIMETICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fglycomimetics-inc-1253689)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 101 Orchard Ridge Drive, Suite 1E, Gaithersburg, MD, 20878
- Phone: (240) 243-1201
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1253689

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 27, 2010 | Amendment | $50,000,000 | $38,979,412 | $11,020,588 | 15 | Oct 20, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1253689/000114036110042357/0001140361-10-042357-index.htm) |
| Nov 4, 2009 | New notice | $15,315,525 | $15,315,525 | $0 | 10 | Jul 3, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1253689/000114036109024718/0001140361-09-024718-index.htm) |
| Nov 4, 2009 | New notice | $50,000,000 | $38,979,412 | $11,020,588 | 15 | Oct 20, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1253689/000114036109024717/0001140361-09-024717-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| M. James Barrett | Director |  |
| Michael James Henos | Director |  |
| Franklin James Top | Director |  |
| Helen Thackray | Executive Officer |  |
| Rachel King | Executive Officer, Director |  |
| John Magnani | Executive Officer, Director |  |
| John James Baldwin | Director |  |
| William James Gust | Director |  |

[Every Form D from the week of Oct 25, 2010](https://specstream.ai/data/form-d/week/2010-10-25) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what GLYCOMIMETICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).